Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uricemin in patients with hyperuricemia
NCT04161872Phase 4Completed
- Sponsor
- University of Pavia
- Start
- Oct 2018
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hyperuricemia, sponsored by University of Pavia. Primary endpoint: Variation of Hyperuricemia at 3 months. Started Oct 2018; status: completed.
02
Conditions
hyperuricemia
Beyond the preview
Go deeper on NCT04161872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04161872.